Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
JHEP Reports : Innovation in Hepatology|December 24, 2025
L actococcus A phages predict ACLF while Enterococcus B phages predict bacterial infection in decompensated cirrhosisLore Van Espen, Maximilian Joseph Brol, Lila Close, et al.
JHEP Reports : Innovation in Hepatology|August 9, 2023
Myostatin is associated with the presence and development of acute-on-chronic liver failureAstrid Ruiz-Margáin, Alessandra Pohlmann, Silke Lanzerath, et al.
The Lancet Regional Health. Europe|December 13, 2021
Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018)Wenyi Gu, Hannah Hortlik, Hans-Peter Erasmus, et al.
Hepatology Communications|September 14, 2023
Use and outcome of TIPS in hospitalized patients in Germany: A Nationwide study (2007-2018)Wenyi Gu, Yasmin Zeleke, Hannah Hortlik, et al.
Science Advances|April 3, 2026
Posttranscriptional reprogramming controls MASLD progression through chronic ER stress adaptationEulalia Belloc, Vittorio Calderone, Salvador Naranjo-Suarez, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 13, 2025
Metabolic Signatures of Acinetobacter baumannii and Klebsiella pneumoniae Infections in Acute-on-chronic Liver FailureCamilla Cadoli, Sania Arif, Wibke Ballhorn, et al.
JHEP Reports : Innovation in Hepatology|February 25, 2026
Development and patterns of acute-on-chronic liver failure in patients with cirrhosis and acute kidney injurySusan Fischer, Martin Sebastian McCoy, Marta Fiocco, et al.
Hepatology (Baltimore, Md.)|August 22, 2022
Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosisSandra Torres, Cristina Ortiz, Nadine Bachtler, et al.
JHEP Reports : Innovation in Hepatology|March 20, 2026
Higher prevalence of cytomegalovirus and Epstein-Barr virus in acute-on-chronic liver failureKeerthihan Thiyagarajah, Jannik Sonnenberg, Esra Görgülü, et al.
Journal of Hepatology|March 29, 2024
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseasesMaja Thiele, Ida Falk Villesen, Lili Niu, et al.
Pageof 3